Met Life Investment Management, LLC Arvinas, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

A detailed history of Met Life Investment Management, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 37,180 shares of ARVN stock, worth $919,833. This represents 0.01% of its overall portfolio holdings.

Number of Shares
37,180
Previous 26,183 42.0%
Holding current value
$919,833
Previous $1.08 Million 8.43%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$24.46 - $40.4 $268,986 - $444,278
10,997 Added 42.0%
37,180 $989,000
Q1 2024

May 14, 2024
BUY
$36.38 - $52.31 $952,537 - $1.37 Million
26,183 New
26,183 $1.08 Million
Q3 2023

May 09, 2024
BUY
$19.64 - $28.21 $16,360 - $23,498
833 Added 3.29%
26,183 $514,000
Q2 2023

Apr 29, 2024
BUY
$21.73 - $31.43 $568,956 - $822,931
26,183 New
26,183 $649,000
Q2 2023

Aug 10, 2023
BUY
$21.73 - $31.43 $18,101 - $26,181
833 Added 3.29%
26,183 $649,000
Q1 2023

May 09, 2024
BUY
$26.15 - $37.26 $662,902 - $944,541
25,350 New
25,350 $693 Million
Q1 2022

May 10, 2024
BUY
$60.27 - $81.57 $1.53 Million - $2.07 Million
25,350 New
25,350 $1.71 Million
Q1 2022

Mar 22, 2023
BUY
$60.27 - $81.57 $544,780 - $737,311
9,039 Added 55.42%
25,350 $1.71 Million
Q1 2022

May 12, 2022
BUY
$60.27 - $81.57 $544,780 - $737,311
9,039 Added 55.42%
25,350 $1.71 Million
Q4 2021

May 17, 2024
BUY
$65.85 - $96.21 $41,419 - $60,516
629 Added 4.01%
16,311 $1.34 Million
Q4 2021

Jun 21, 2023
SELL
$65.85 - $96.21 $595,218 - $869,642
-9,039 Reduced 35.66%
16,311 $1.34 Million
Q4 2021

Mar 22, 2023
BUY
$65.85 - $96.21 $41,419 - $60,516
629 Added 4.01%
16,311 $1.34 Million
Q4 2021

Feb 15, 2022
BUY
$65.85 - $96.21 $41,419 - $60,516
629 Added 4.01%
16,311 $1.34 Million
Q3 2021

Jun 21, 2023
SELL
$73.2 - $107.87 $707,697 - $1.04 Million
-9,668 Reduced 38.14%
15,682 $1.29 Million
Q2 2021

May 17, 2024
BUY
$60.45 - $84.26 $144,838 - $201,886
2,396 Added 18.03%
15,682 $1.21 Million
Q2 2021

Jun 21, 2023
SELL
$60.45 - $84.26 $584,430 - $814,625
-9,668 Reduced 38.14%
15,682 $1.21 Million
Q2 2021

Mar 22, 2023
BUY
$60.45 - $84.26 $144,838 - $201,886
2,396 Added 18.03%
15,682 $1.21 Million
Q2 2021

Aug 16, 2021
BUY
$60.45 - $84.26 $144,838 - $201,886
2,396 Added 18.03%
15,682 $1.21 Million
Q1 2021

May 17, 2024
SELL
$58.19 - $91.37 $750,476 - $1.18 Million
-12,897 Reduced 49.26%
13,286 $878,000
Q1 2021

Jun 26, 2023
SELL
$58.19 - $91.37 $702,004 - $1.1 Million
-12,064 Reduced 47.59%
13,286 $878 Million
Q4 2020

Jun 22, 2023
SELL
$20.19 - $84.93 $243,572 - $1.02 Million
-12,064 Reduced 47.59%
13,286 $1.13 Million
Q3 2020

Jun 26, 2023
SELL
$22.99 - $36.34 $277,351 - $438,405
-12,064 Reduced 47.59%
13,286 $313,000
Q2 2020

May 24, 2024
SELL
$29.88 - $56.74 $385,362 - $731,775
-12,897 Reduced 49.26%
13,286 $446 Million
Q2 2020

Jun 26, 2023
SELL
$29.88 - $56.74 $360,472 - $684,511
-12,064 Reduced 47.59%
13,286 $445,000
Q2 2020

Mar 22, 2023
BUY
$29.88 - $56.74 $134,460 - $255,330
4,500 Added 51.22%
13,286 $445,000
Q2 2020

Aug 14, 2020
BUY
$29.88 - $56.74 $134,460 - $255,330
4,500 Added 51.22%
13,286 $446,000
Q1 2020

Jul 12, 2023
SELL
$33.0 - $54.5 $546,612 - $902,738
-16,564 Reduced 65.34%
8,786 $354,000
Q4 2019

Jul 12, 2023
SELL
$15.39 - $44.38 $254,919 - $735,110
-16,564 Reduced 65.34%
8,786 $361,000
Q3 2019

Jul 12, 2023
SELL
$21.55 - $27.61 $356,954 - $457,332
-16,564 Reduced 65.34%
8,786 $189,000
Q3 2019

Mar 22, 2023
SELL
$21.55 - $27.61 $356,954 - $457,332
-16,564 Reduced 65.34%
8,786 $189,000
Q3 2019

Nov 14, 2019
BUY
$21.55 - $27.61 $189,338 - $242,581
8,786 New
8,786 $189,000
Q2 2019

Jul 12, 2023
SELL
$15.96 - $23.8 $264,361 - $394,223
-16,564 Reduced 65.34%
8,786 $193 Million

Others Institutions Holding ARVN

# of Institutions
224
Shares Held
68.7M
Call Options Held
166K
Put Options Held
31.3K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.32B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email